MetLife Investment Management’s Verso Corporation VRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-4,675
| Closed | -$126K | – | 2959 |
|
|
2022
Q1 | $126K | Sell |
4,675
-3,209
| -41% | -$85.8K | ﹤0.01% | 2578 |
|
|
2021
Q4 | $213K | Hold |
7,884
| – | – | ﹤0.01% | 2017 |
|
|
2021
Q3 | $164K | Sell |
7,884
-4,268
| -35% | -$82.3K | ﹤0.01% | 2207 |
|
|
2021
Q2 | $215K | Hold |
12,152
| – | – | ﹤0.01% | 2124 |
|
|
2021
Q1 | $177K | Buy |
12,152
+6,326
| +109% | +$83.2K | ﹤0.01% | 2118 |
|
|
2020
Q4 | $70K | Sell |
5,826
-2,856
| -33% | -$28.3K | ﹤0.01% | 2246 |
|
|
2020
Q3 | $68.5K | Sell |
8,682
-8,131
| -48% | -$98.9K | ﹤0.01% | 2256 |
|
|
2020
Q2 | $201K | Hold |
16,813
| – | – | ﹤0.01% | 1904 |
|
|
2020
Q1 | $190K | Hold |
16,813
| – | – | ﹤0.01% | 1730 |
|
|
2019
Q4 | $303K | Hold |
16,813
| – | – | ﹤0.01% | 1742 |
|
|
2019
Q3 | $208K | Hold |
16,813
| – | – | ﹤0.01% | 1923 |
|
|
2019
Q2 | $320K | Hold |
16,813
| – | – | ﹤0.01% | 1754 |
|
|
2019
Q1 | $360K | Hold |
16,813
| – | – | ﹤0.01% | 1647 |
|
|
2018
Q4 | $377K | Hold |
16,813
| – | – | ﹤0.01% | 1534 |
|
|
2018
Q3 | $566K | Hold |
16,813
| – | – | 0.01% | 1456 |
|
|
2018
Q2 | $366K | Hold |
16,813
| – | – | ﹤0.01% | 1603 |
|
|
2018
Q1 | $283K | Hold |
16,813
| – | – | ﹤0.01% | 1710 |
|
|
2017
Q4 | $295K | Buy |
+16,813
| New | +$161K | ﹤0.01% | 1722 |
|
MetLife Investment Management's VRS Position: Q2 2022 in Review
MetLife Investment Management sold out of Verso Corporation (VRS) in Q2 2022, closing a stake of 4,675 shares — an estimated $126K sold.
MetLife Investment Management first reported a position in VRS in Q4 2017 and held it in 18 quarters. The position peaked at $566K in Q3 2018. 0 funds tracked by Wall St. Rank hold VRS as of Q2 2022.
- MetLife Investment Management reported no remaining Verso Corporation position as of Q2 2022 after selling out during the quarter.
- MetLife Investment Management sold 4,675 Verso Corporation shares in Q2 2022, an estimated $126K.
- MetLife Investment Management first reported a position in Verso Corporation in Q4 2017 and held it in 18 quarters.
- MetLife Investment Management's Verso Corporation position peaked at $566K in Q3 2018.
- 0 funds tracked by Wall St. Rank held Verso Corporation as of Q2 2022.
Based on MetLife Investment Management's 13F filing for Q2 2022, filed 11 Aug 2022.